Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication

Thrombosis Research

Volumn 130, Issue 1, 2012, Pages 99-103

  Rajzer, Marek ^a   Wojciechowska, Wiktoria ^a   Kawecka Jaszcz, Kalina ^a   Undas, Anetta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

antihypertensive treatment; arterial hypertension; fibrin clot properties; fibrinolysis

Indexed keywords

AMLODIPINE; BISOPROLOL; CHOLESTEROL; COMPLEMENT COMPONENT C3; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; QUINAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRIN CLOT; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION;

ADULT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD COAGULATION; FEMALE; FIBRIN; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; TETRAHYDROISOQUINOLINES;

EID: 84861807979     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.08.022     Document Type: Article

References (43)

1. A.D. Lopez, C.D. Mathers, and M. Ezzati Global Burden of Disease and Risk Factors A co-publication of Oxford University Press and The World Bank 10:0-8213 2006 The International Bank of Reconstruction and Development/The World Bank and Oxford University Press New York 6262 6263
2. S. MacMahon, R. Peto, and J. Cutler Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
3. R. Collins, R. Peto, and S. MacMahon Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 839
4. K. Miura, M.L. Daviglus, and A.R. Dyer Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry Arch Intern Med 161 2001 1501 1508
5. G.Y.H. Lip, and F.L. Li-Saw-He Does hypertension confer a hypercoagulable state? J Hypertens 16 1998 913 916
6. P. Kakar, and G.Y.H. Lip Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy Expert Rev Cardiovasc Ther 5 2007 441 450
7. M. Eliasson, P.E. Evrin, and D. Lundblad Fibrinogen and fibrinolytic variables in relation to anthropometry lipids and blood pressure. The Northern Sweden MONICA Study J Clin Epidemiol 47 1994 513 524
8. T.K. Makris, C. Tsoukala, and P. Krespi Haemostasis balance disorders in patients with essential hypertension Thromb Res 88 1997 99 107
9. R. Junker, J. Heinrich, and H. Schulte Haemostasis in normotensive and hypertensive men: results of the PROCAM study J Hypertens 16 1998 917 923
10. G.Y.H. Lip, A.D. Blann, and A.F. Jones Relationship of endothelium, thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy Am J Cardiol 80 1997 1566 1571
11. W.C.S. Smith, G.D.O. Lowe, and A.J. Lee Rheological determinants of blood pressure in a Scottish adult population J Hypertens 10 1992 467 472
12. F.G.R. Fowkes, G.D.O. Lowe, and A. Rumley The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years Eur Heart J 4 1993 1023 1036
13. C.G.C. Spencer, D. Gurney, and A.D. Blann Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension Hypertension 40 2002 61 66
14. A.R. Folsom, J.M. Peacock, and F.J. Nieto Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study J Hypertens 16 1998 1579 1583
15. L.A. Sechi, L. Zingaro, and C. Catena Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension Hypertension 36 2000 978 985
16. K.A. Poli, G.H. Tofler, and M.G. Larson Association of blood pressure with fibrinolytic potential in the Framingham offspring population Circulation 101 2000 264 269
17. Y.A. Ding, H.W. Law, and T.C. Chou Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, rheological and platelet function in hypertensive patients J Hum Hypertens 8 1994 137 143
18. M. Ekholm, N.H. Wallen, and H. Johnsson Long term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension Clin Sci 103 2002 151 155
19. G.P. Vyssoulis, A.G. Marinakis, and K.A. Aznaouridis The impact of third-generation Beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state Am J Hypertens 17 2004 582 589
20. T.K. Makris, G. Stavroulakis, and D.P. Papadopoulos Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan Drugs Exp Clin Res 30 2004 125 132
21. C.R. Gibbs, A.D. Blann, and R.D.S. Watson Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and ß-blocker therapy Circulation 103 2001 1746 1751
22. B. Blombäck Fibrinogen and fibrin - proteins with complex roles haemostasis and thrombosis Thromb Res 83 1996 1 75
23. E.M. Scott, R.A.S. Ariëns, and P.J. Grant Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease Arterioscler Thromb Vasc Biol 24 2004 1558 1566
24. A. Undas, K. Szułdrzyński, and E. Stepien Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress Atherosclerosis 196 2008 551 557
25. A. Undas, A. Slowik, and P. Wołkow Fibrin clot properties in acute ischemic stroke: relation to neurological deficit Thromb Res 125 2010 357 361
26. A.M. Carter, C.M. Cymbalista, and T.D. Spector Heritability of clot formation, morphology and lysis. The EuroCLOT Study Arterioscler Thromb Vasc Biol 27 2007 2783 2789
27. A. Undas, M. Celińska-Lowenhoff, and T. Lowenhoff Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease J Thromb Haemost 4 2006 1029 1036
28. G. Mancia, G. de Baker, and A. Dominiczak Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
29. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia Report of a WHO/IDF Consultation. 1. Diabetes mellitus - diagnosis. 2. Diabetes mellitus - classification. 3. Hyperglycemia.4.Glucose tolerance test. I-World Health Organization. II- International Diabetes Federation. © World Health Organization 2006 Printed by the WHO Document Production Services, Geneva, Switzerland
30. M. El Assad, J. Topouchian, and R. Asmar Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT Blood Press Monit 8 2003 127 133
31. J.P. Collet, Z. Mishal, and C. Lesty Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications Thromb Haemost 82 1999 1482 1489
32. A. Undas, K. Zawilska, and M. Ciesla-Dul Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
33. J. Chalmers, and H. Arima Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials Pol Arch Med Wewn 119 2009 373 380
34. R. Fagard Reappraisal of the European guidelines on hypertension management: the European Society of Hypertension Task Force document: a short review Pol Arch Med Wewn 120 2010 31 35
35. E. Rooth, N.H. Wallen, M. Blombäck, and S. He Decreased fibrin clot network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke Thromb Res 127 2011 51 56
36. J.A. Papadakis, D.P. Mikhailidis, and G.E. Vrentzos Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension Clin Appl Thromb Hemost 11 2005 139 146
37. P. Théroux, and C. Martel Complement activity and pharmacological inhibition in cardiovascular disease Can J Cardiol 22 Suppl. B 2006 18B 24B
38. G. Engström, B. Hedblad, G. Berglund, L. Janzon, and F. Lindgärde Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study J Hum Hypertens 21 2007 276 282
39. R. Ajjan, P.J. Grant, and T.S. Futers Complement C3 and C-reactive protein levels in patients with stable coronary artery disease Thromb Haemost 94 2005 1048 1053
40. E. Obarzanek, F.M. Sacks, and V.M. Vollmer Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial Am J Clin Nutr 74 2001 80 89
41. K. Fatah, A. Hamsten, and B. Blomback Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins, and coronary atherosclerosis Thromb Haemost 68 1992 130 135
42. A. Undas, D. Plicner, and E. Stepien Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a), and homocysteine J Thromb Haemost 5 2007 1988 1990
43. A. Undas, P. Kaczmarek, and K. Sladek Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment Thromb Haemost 102 2009 1176 1182